526546 — Choksi Laboratories Income Statement
0.000.00%
Last trade - 00:00- IN₹1.20bn
- IN₹1.49bn
- IN₹417.82m
- 68
- 16
- 91
- 64
Annual income statement for Choksi Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 257 | 300 | 344 | 367 | 418 |
| Cost of Revenue | |||||
| Gross Profit | 225 | 274 | 322 | 341 | 377 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 262 | 266 | 274 | 322 | 370 |
| Operating Profit | -4.78 | 34.6 | 70 | 45.1 | 47.4 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -28.1 | 3.67 | 37.2 | 16.6 | 21.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -26.1 | 2.07 | 32.1 | 11.1 | 15.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -26.1 | 2.07 | 32.1 | 11.1 | 15.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26.1 | 2.07 | 32.1 | 11.1 | 15.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.75 | 0.294 | 1.82 | 1.6 | 2.19 |
| Dividends per Share |